Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Reviews
Customer Reviews
Application Protocols
The Product Data do not include validated application protocols for AZD-6280. The following general procedures are commonly used for small-molecule screening compounds and should be adapted to your assay and compound behavior.
General small-molecule handling (in vitro):
Stock preparation: Dissolve in anhydrous DMSO to 10–50 mM. Sonicate gently and, if needed, warm to 30–40 °C briefly. Inspect for clarity; filter through 0.22 µm PTFE if particulate persists.
Serial dilution: Prepare intermediate DMSO dilutions (e.g., 8-point 3-fold series). Back-dilute into assay buffer to achieve final DMSO ≤0.5–1.0% v/v.
Plate handling: Use low-binding plates/tips; seal plates to limit evaporation. Include vehicle controls and, if available, positive/negative controls.
Stability check: At mid-dose, sample the assay mixture at T0 and endpoint for LC–MS to confirm compound persistence and exclude adsorption/precipitation artifacts.
Biophysical/biochemical modalities:
Enzyme assays: Validate linear range and confirm absence of assay interference (e.g., redox cycling, metal chelation, aggregation via detergent controls).
Cell assays: Verify cell tolerability to vehicle; pre-test for fluorescence/absorbance overlap if using optical readouts.
These are non-validated, general guidelines; optimize for your specific system.
Biological Roles
No target class or MOA is provided in the Product Data for AZD-6280. Therefore, no item-specific biological role can be stated here. The following are general considerations for small-molecule screening compounds used in discovery biology.
Potential roles in research: Putative ligand for receptor/enzyme/protein interaction studies, phenotypic screening hit, or chemical probe candidate pending validation.
Characterization workflow: Determine binding/functional activity using appropriate in vitro assays (e.g., enzymatic turnover, reporter gene assays, electrophysiology), followed by counterscreens for selectivity, off-targets, and assay interference (e.g., redox cycling, fluorescence quenching/auto-fluorescence, aggregation).
ADME profiling (research context): Aqueous solubility, permeability (PAMPA/Caco-2), microsomal stability, and plasma protein binding are common early measurements; results are highly structure-dependent and must be generated empirically for this item.
Data integrity: Include vehicle controls and replicate measurements across independent lots when feasible. Track exact plate history and storage conditions to ensure reproducibility.
Note: For research use only. No clinical or diagnostic use is intended or implied.
Buffer Applications
This product is not a buffering agent and does not define a specific buffer system. However, buffers are commonly required for its use in biochemical and cellular assays.
Practical guidance (general):
Common assay buffers: PBS (pH 7.2–7.4), HEPES (pH 7.2–7.6), Tris (pH 7.4–8.0), or assay-specific formulations. Ensure compatibility of the buffer with the biological target and detection modality.
Solvent tolerance: Maintain final DMSO at or below the assay’s validated limit (often 0.1–1.0% v/v). Pre-equilibrate buffers to temperature and add compound stocks last to minimize precipitation.
Additives: If needed to aid solubilization, consider limited amounts of cyclodextrins (e.g., 2–10 mM HP-β-CD) or non-ionic surfactants (0.01–0.05% Tween-20/80), verifying no interference with your readout.
Filtration: For sterile applications, filter buffers through 0.22 µm PES/RC membranes. Avoid PVDF for strongly hydrophobic analytes due to adsorption.
Prepare small, fresh working solutions to minimize compound degradation and adsorption losses.
Green Alternatives
As a screening compound (not a reaction solvent or bulk reagent), traditional green-chemistry substitutions are less applicable. Environmental impact is driven more by solvent use in handling, dissolution, and purification.
Greener handling suggestions (general):
Prefer lower-toxicity, rapidly biodegradable solvents where assay compatibility allows: ethanol over isopropanol over acetonitrile/DMF. However, DMSO remains the most versatile for stocks; keep final v/v% minimal.
Minimize solvent volumes for plate preparation; use acoustic dispensing or positive-displacement technologies to reduce waste.
Implement micro-scale analytics (UPLC, miniaturized LC–MS) to cut solvent consumption versus traditional HPLC.
Consolidate freeze–thaw and dispensing steps to reduce consumables and dry ice usage; plan batch aliquoting.
Illustrative comparison (general):
DMSO vs DMF: DMSO has lower volatility/odor and broad solvency; DMF poses higher regulatory scrutiny. Use DMSO when possible.
Acetonitrile vs ethanol: Acetonitrile offers superior volatility and LC compatibility but is petro-derived and toxic; ethanol is greener but may disrupt some assays. Choose per assay tolerance.
Pharmaceutical Uses
No pharmacopeial status, excipient role, or formulation use is provided for AZD-6280 in the Product Data. This item is supplied strictly for research applications.
General considerations relevant to discovery/formulation research (non-clinical):
Preformulation screening: Determine solubility across pH 1–8 buffers, cosolvent systems (e.g., PEG400, ethanol, propylene glycol), and potential enabling technologies (e.g., cyclodextrin inclusion, lipid-based vehicles) for in vivo exploratory studies in appropriate animal models (if permitted by your institution and regulations).
Solid-state assessment: If material is crystalline, evaluate polymorphism, hygroscopicity, and thermal stability by DSC/TGA/PXRD prior to long-term storage studies.
Impurity control: Track process- and storage-related degradants by stability-indicating LC–MS methods.
No therapeutic or clinical claims are made. For research use only.
Physical Properties
Item-specific physicochemical data are not provided in the Product Data. Do not assume values as specifications for QC purposes.
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight (MW): Not specified for this item; refer to CoA/Spec Sheet.
Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
Melting point (MP): Not specified for this item; refer to CoA/Spec Sheet.
Boiling point (BP): Not specified for this item; refer to CoA/Spec Sheet.
Density: Not specified for this item; refer to CoA/Spec Sheet.
Refractive index: Not applicable to solids; if liquid/oil, Not specified for this item; refer to CoA/Spec Sheet.
Aqueous/organic solubility: Not specified for this item; determine empirically (see below) or refer to CoA/Spec Sheet.
pKa/logP/logD: Not specified for this item; consult literature or perform in-house measurements.
Practical guidance (general/literature best practice):
For library compounds, initial dissolution is commonly evaluated in anhydrous DMSO at 10–50 mM. If insoluble, consider co-solvent systems (e.g., DMSO:acetonitrile or DMSO:ethanol) and gentle warming (<40 °C) with sonication.
Determine kinetic and thermodynamic solubility in relevant assay buffers (e.g., PBS, HBSS) at working pH, keeping final DMSO ≤0.5–1.0% v/v where assay-sensitive.
Verify purity and identity by LC–MS and HPLC-UV prior to biological testing. Record retention time and UV profile as internal reference for future lots.
Quality & Grades
Grade/purity information is not provided in the Product Data; do not infer assay suitability or purity thresholds. For exact release criteria, request the current CoA/Spec Sheet for the specific lot.
What to expect and how to use QC data effectively:
If a purity value is reported on the CoA (e.g., HPLC area %), note the detection wavelength(s), gradient, and method details, as UV purity may differ from ELSD/charged aerosol results for weak chromophores.
Confirm identity by LC–MS (m/z of [M+H]+ / [M−H]−), and, if required, by 1H/13C NMR. For critical applications, consider HRMS and KF moisture if hygroscopicity is suspected.
Stabilizers/antioxidants: Not specified for this item; refer to CoA/Spec Sheet. If none are present, handle under inert atmosphere if the compound is air/oxidation sensitive.
Interpreting common research grades (general guidance):
“Screening/Library grade” compounds are typically suitable for in vitro biochemical/cellular assays after standard in-lab verification (identity/purity/solubility). Low residual solvent and low non-volatile impurities are preferred for reproducibility.
Absence of grade information warrants in-house QC prior to HTS or SAR decision-making.
Reaction & Applications
This product is supplied as a finished small-molecule research compound rather than a general-purpose reagent. It is primarily used in discovery biology and cheminformatics workflows rather than as a substrate/solvent for synthetic reactions.
Research applications (general):
Tool or library member for primary screening, secondary confirmation, and early SAR activities in biochemical or cell-based assays.
Reference material for orthogonal assay validation (e.g., comparing readouts across fluorescence, luminescence, and MS-based formats).
Control in plate-based QC (e.g., solubility/precipitation controls, carryover checks) when its behavior is characterized in your lab.
Practical tips:
Establish a robust handling protocol: prepare a 10–50 mM DMSO master stock, confirm clarity (no visible precipitate), and perform serial dilutions immediately before use.
Record and track plate layouts, final DMSO concentrations, and any cosolvents. Monitor compound stability in assay media by LC–MS at relevant timepoints.
If the compound is light- or oxidation-sensitive (unknown here), use amber vials/plates and an inert headspace (N2/Ar), minimizing freeze–thaw cycles via aliquoting.
Reaction Conditions
Not typically applicable. AZD-6280 is supplied as a research compound rather than a reagent for running chemical reactions. No item-specific catalytic or stoichiometric roles are claimed.
If you are modifying the scaffold (medicinal chemistry context), reaction conditions will depend entirely on the verified structure and functional groups present. General considerations include:
Protecting-group strategy to preserve sensitive heterocycles or amines; select orthogonal deprotection conditions.
Use of mild cross-coupling conditions (e.g., Pd-catalyzed Suzuki–Miyaura in aqueous-organic solvent systems) for diversification, or Cu-mediated N-arylation when appropriate.
Control of chemoselectivity, especially for multi-functional molecules, through base choice, solvent polarity, and temperature.
No literature conditions specific to this item are cited here; consult primary references once the exact structure is confirmed.
Safety & Handling
Hazard data specific to this item are not supplied in the Product Data. Always consult the product SDS for authoritative information.
GHS Classification: Not specified for this item; refer to SDS.
Signal word / H-statements / Pictograms: Not specified for this item; refer to SDS.
General laboratory precautions for small-molecule research compounds:
Handle in a chemical fume hood. Avoid inhalation of dust/aerosols and contact with skin/eyes.
Personal protective equipment: lab coat, safety glasses, and appropriate chemical-resistant gloves (e.g., nitrile). Change gloves frequently and avoid cross-contamination of screening plates.
Avoid sources of ignition and static discharge if material is volatile or supplied in organic solvents.
Storage incompatibilities: Keep away from strong oxidizers and acids/bases until compatibility is known. Protect from moisture and light unless otherwise specified.
First aid (overview, defer to SDS): in case of skin/eye contact, rinse with water for ≥15 min; if inhaled, move to fresh air; if ingested, seek medical attention. Provide SDS to responders.
Special handling and shipping:
Storage Conditions: Store at −80 °C (per Product Data).
Shipped: On dry ice packs + cold packs (per Product Data). Minimize freeze–thaw cycles post-receipt; aliquot upon first opening to maintain integrity.
Solvent Selection
Item-specific polarity and solubility parameters are not provided. Solvent choice should be confirmed empirically for your lot and assay context.
General best practices for small-molecule screening compounds:
Primary stock solvent: Anhydrous DMSO is the default for many discovery compounds due to broad solvating ability and assay compatibility at ≤0.5–1.0% v/v final concentration.
Co-solvent strategies: If solubility in DMSO is limited, trial mixtures such as DMSO:acetonitrile (1:1), DMSO:ethanol (4:1), or DMSO:DMF (4:1). Filter sterilize if required for cell-based assays (0.22 µm PTFE/RC).
Aqueous compatibility: Use surfactant-containing buffers (e.g., 0.01–0.05% Tween-80) only if validated for the assay target; note that surfactants may affect membrane proteins and readouts.
Adsorption mitigation: For sticky/lipophilic compounds, reduce nonspecific binding by using low-binding plastics, adding carrier proteins (e.g., 0.1% BSA) if assay-tolerated, and maintaining consistent DMSO.
When to consider alternatives:
Acetonitrile or ethanol can be preferred where DMSO interferes with enzyme kinetics or spectral windows.
For NMR, deuterated DMSO-d6, CDCl3, or CD3OD may be used depending on solubility and stability; verify no protic exchange with labile sites.
Always document solvent composition in data records for reproducibility.
Storage & Reconstitution
Storage and shipping conditions are provided; additional practical guidance is included for maintaining integrity in discovery workflows.
Storage Conditions: Store at −80 °C (per Product Data). Protect from moisture and light unless otherwise stated on the CoA.
Stability: Lot-specific stability is not specified; refer to CoA/Spec Sheet. As a best practice, minimize freeze–thaw cycles by preparing single-use aliquots upon first opening.
Reconstitution (general guidance):
Solvent: Use anhydrous DMSO for initial stock solutions (typical 10–50 mM). If insoluble, consider co-solvents (e.g., ACN, EtOH) compatible with your assay.
Technique: Bring vial to low temperature (e.g., on ice or at 4 °C) before opening in a low-humidity environment to avoid condensation. Add solvent directly to the vial, cap, vortex, and sonicate if needed. Avoid headspace moisture.
Aliquoting: Distribute reconstituted stock into inert, low-bind microtubes or 96/384-well plates, seal tightly, and store at −80 °C. Record the number of freeze–thaw events.
Working solutions: Prepare fresh on the day of use; limit total time at room temperature. Filter if particulates appear and verify concentration by UV or LC–MS when critical.
For research use only. Always consult the lot-specific CoA and SDS for definitive instructions.
Structure & Identity
Brief overview: AZD-6280 is an AstraZeneca-designated small-molecule research compound supplied for screening and discovery workflows. Item-specific structural identifiers are limited in the Product Data.
SKU: A655536
Product Name: AZD-6280
CAS: 942436-93-3 (identifier)
PubChem CID: 23630026 (identifier)
Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
SMILES: Not specified for this item; refer to CoA/Spec Sheet.
InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
Structural features (general notes):
Small-molecule research compound typically used as a screening hit/lead. Specific functional groups, ring systems, and stereochemistry are not provided in the current listing and should be confirmed against the CoA or by in-house characterization (e.g., 1H/13C NMR, HRMS, LC–MS, and, if relevant, chiral HPLC).
2D structure description (general):
Without a supplied structure, a descriptive 2D topology cannot be provided. Users should retrieve the structural diagram from the CoA/Spec Sheet or a trusted structure database aligned to CAS 942436-93-3, then verify by analytical comparison to the delivered lot.
Synthetic Utility
AZD-6280 is offered as a finished small molecule for screening rather than a building block or reagent, so it is not typically employed as a starting material in synthetic sequences.
For medicinal chemistry workflows (general guidance):
Lead optimization: If the structure is disclosed in your program, derivatization around key pharmacophores, heteroaromatic substitution patterns, or stereocenters can be pursued to modulate potency, selectivity, and ADME properties.
Analog synthesis: Plan robust convergent routes with interchangeable fragments to explore SAR efficiently. Choose chemoselective transformations compatible with late-stage diversification (e.g., Suzuki–Miyaura, Buchwald–Hartwig, Minisci, C–H activation) if the scaffold allows.
Purification and analytics: Anticipate closely eluting positional isomers; leverage 2D LC or supercritical fluid chromatography (SFC) where applicable. Employ HRMS and NMR (including HMBC/HSQC/NOESY) for full assignment.
Because item-specific functional groups and reactivity are not provided, any synthetic use must be based on a verified structure from the CoA or internal characterization.
Target Specificity
No target, mechanism of action, or selectivity profile is provided in the Product Data for AZD-6280.
Target/epitope: Not specified for this item; refer to CoA/Spec Sheet or internal program data.
Species reactivity or panel coverage: Not specified for this item; generate empirically via biochemical/cell-based assays and broad off-target screening where relevant.
Note: Any claims of specificity should be supported by your own assay data (e.g., Kd/IC50/EC50 with confidence intervals) and counterscreens for frequent hitters or assay interference.
Frequently Asked Questions
How should this product be stored?
Store at ?80 °C. Ultra-low temperature storage is required to maintain the specified shelf life.
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.
Shall we send you a message when we have discounts available?
Remind me later
Thank you! Please check your email inbox to confirm.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
